Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2004

01-11-2004 | Viewpoint

Direct interaction of immunoglobulins with synovial fibroblasts: a missing link in the pathogenesis of rheumatoid arthritis?

Author: Thomas Pap

Published in: Arthritis Research & Therapy | Issue 1/2004

Login to get access

Excerpt

It has been well established that the pathogenesis of rheumatoid arthritis (RA) comprises three distinct but interdependent phenomena: the hyperplasia of synovial tissue, chronic inflammation (both local and systemic), and alterations in the immune response, including changes in the T-cell repertoire and the production of autoantibodies [1]. The precise nature of these interactions, however, particularly the role of autoantibodies in RA pathogenesis, is not yet fully understood. Whilst the occurrence of autoantibodies has been recognised as a characteristic feature of disease, and certain autoantibodies have become valuable tools for diagnosis, their contribution to the initiation and perpetuation of disease has remained largely elusive. …
Literature
1.
go back to reference Pap T, Gay RE, Gay S: Rheumatoid arthritis. In: The molecular pathology of autoimmune diseases. Edited by: Theofilopoulos AN, Bona CA. 2002, New York: Taylor & Francis, 376-401. 2 Pap T, Gay RE, Gay S: Rheumatoid arthritis. In: The molecular pathology of autoimmune diseases. Edited by: Theofilopoulos AN, Bona CA. 2002, New York: Taylor & Francis, 376-401. 2
2.
go back to reference Pritchard J, Tsui S, Horst N, Cruikshank WW, Smith TJ: Synovial fibroblasts from patients with rheumatoid arthritis, like fibroblasts from Graves' disease, express high levels of IL-16 when treated with Igs against insulin-like growth factor-1 receptor. J Immunol. 2004, 173: 3564-3569.CrossRefPubMed Pritchard J, Tsui S, Horst N, Cruikshank WW, Smith TJ: Synovial fibroblasts from patients with rheumatoid arthritis, like fibroblasts from Graves' disease, express high levels of IL-16 when treated with Igs against insulin-like growth factor-1 receptor. J Immunol. 2004, 173: 3564-3569.CrossRefPubMed
3.
go back to reference O'Toole EA, Mak LL, Guitart J, Woodley DT, Hashimoto T, Amagai M, Chan LS: Induction of keratinocyte IL-8 expression and secretion by IgG autoantibodies as a novel mechanism of epidermal neutrophil recruitment in a pemphigus variant. Clin Exp Immunol. 2000, 119: 217-224. 10.1046/j.1365-2249.2000.01104.x.PubMedCentralCrossRefPubMed O'Toole EA, Mak LL, Guitart J, Woodley DT, Hashimoto T, Amagai M, Chan LS: Induction of keratinocyte IL-8 expression and secretion by IgG autoantibodies as a novel mechanism of epidermal neutrophil recruitment in a pemphigus variant. Clin Exp Immunol. 2000, 119: 217-224. 10.1046/j.1365-2249.2000.01104.x.PubMedCentralCrossRefPubMed
4.
go back to reference Heufelder AE, Bahn RS: Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts. Eur J Clin Invest. 1992, 22: 529-537.CrossRefPubMed Heufelder AE, Bahn RS: Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts. Eur J Clin Invest. 1992, 22: 529-537.CrossRefPubMed
5.
go back to reference Rotella CM, Zonefrati R, Toccafondi R, Valente WA, Kohn LD: Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J Clin Endocrinol Metab. 1986, 62: 357-367.CrossRefPubMed Rotella CM, Zonefrati R, Toccafondi R, Valente WA, Kohn LD: Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J Clin Endocrinol Metab. 1986, 62: 357-367.CrossRefPubMed
8.
go back to reference Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, Degott C, Kikutani H, Rajewsky K, Pasquali JL, Benoist C, Mathis D: From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity. 1999, 10: 451-461. 10.1016/S1074-7613(00)80045-X.CrossRefPubMed Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, Degott C, Kikutani H, Rajewsky K, Pasquali JL, Benoist C, Mathis D: From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity. 1999, 10: 451-461. 10.1016/S1074-7613(00)80045-X.CrossRefPubMed
9.
go back to reference Matsumoto I, Staub A, Benoist C, Mathis D: Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science. 1999, 286: 1732-1735. 10.1126/science.286.5445.1732.CrossRefPubMed Matsumoto I, Staub A, Benoist C, Mathis D: Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science. 1999, 286: 1732-1735. 10.1126/science.286.5445.1732.CrossRefPubMed
10.
go back to reference Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB: Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science. 2002, 297: 1689-1692. 10.1126/science.1073176.CrossRefPubMed Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB: Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science. 2002, 297: 1689-1692. 10.1126/science.1073176.CrossRefPubMed
11.
go back to reference Pap T, Muller-Ladner U, Gay RE, Gay S: Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2000, 2: 361-367. 10.1186/ar113.PubMedCentralCrossRefPubMed Pap T, Muller-Ladner U, Gay RE, Gay S: Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2000, 2: 361-367. 10.1186/ar113.PubMedCentralCrossRefPubMed
12.
go back to reference Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M: Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 2001, 22: 199-204. 10.1016/S1471-4906(01)01863-4.CrossRefPubMed Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M: Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 2001, 22: 199-204. 10.1016/S1471-4906(01)01863-4.CrossRefPubMed
13.
go back to reference Firestein GS: Evolving concepts of rheumatoid arthritis. Nature. 2003, 423: 356-361. 10.1038/nature01661.CrossRefPubMed Firestein GS: Evolving concepts of rheumatoid arthritis. Nature. 2003, 423: 356-361. 10.1038/nature01661.CrossRefPubMed
14.
go back to reference Pritchard J, Horst N, Cruikshank W, Smith TJ: Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. J Immunol. 2002, 168: 942-950.CrossRefPubMed Pritchard J, Horst N, Cruikshank W, Smith TJ: Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. J Immunol. 2002, 168: 942-950.CrossRefPubMed
15.
go back to reference Kaufmann J, Franke S, Kientsch-Engel R, Oelzner P, Hein G, Stein G: Correlation of circulating interleukin 16 with proinflammatory cytokines in patients with rheumatoid arthritis. Rheumatology. 2001, 40: 474-475. 10.1093/rheumatology/40.4.474.CrossRefPubMed Kaufmann J, Franke S, Kientsch-Engel R, Oelzner P, Hein G, Stein G: Correlation of circulating interleukin 16 with proinflammatory cytokines in patients with rheumatoid arthritis. Rheumatology. 2001, 40: 474-475. 10.1093/rheumatology/40.4.474.CrossRefPubMed
16.
go back to reference Lard LR, Roep BO, Toes RE, Huizinga TW: Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis. J Rheumatol. 2004, 31: 35-39.PubMed Lard LR, Roep BO, Toes RE, Huizinga TW: Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis. J Rheumatol. 2004, 31: 35-39.PubMed
17.
go back to reference Franz JK, Kolb SA, Hummel KM, Lahrtz F, Neidhart M, Aicher WK, Pap T, Gay RE, Fontana A, Gay S: Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis. Eur J Immunol. 1998, 28: 2661-2671. 10.1002/(SICI)1521-4141(199809)28:09<2661::AID-IMMU2661>3.0.CO;2-N.CrossRefPubMed Franz JK, Kolb SA, Hummel KM, Lahrtz F, Neidhart M, Aicher WK, Pap T, Gay RE, Fontana A, Gay S: Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis. Eur J Immunol. 1998, 28: 2661-2671. 10.1002/(SICI)1521-4141(199809)28:09<2661::AID-IMMU2661>3.0.CO;2-N.CrossRefPubMed
18.
go back to reference Klimiuk PA, Goronzy JJ, Weyand CM: IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis. J Immunol. 1999, 162: 4293-4299.PubMed Klimiuk PA, Goronzy JJ, Weyand CM: IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis. J Immunol. 1999, 162: 4293-4299.PubMed
19.
go back to reference Mathy NL, Bannert N, Norley SG, Kurth R: Cutting edge: CD4 is not required for the functional activity of IL-16. J Immunol. 2000, 164: 4429-4432.CrossRefPubMed Mathy NL, Bannert N, Norley SG, Kurth R: Cutting edge: CD4 is not required for the functional activity of IL-16. J Immunol. 2000, 164: 4429-4432.CrossRefPubMed
20.
go back to reference Lynch EA, Heijens CA, Horst NF, Center DM, Cruikshank WW: Cutting edge: IL-16/CD4 preferentially induces Th1 cell migration: requirement of CCR5. J Immunol. 2003, 171: 4965-4968.CrossRefPubMed Lynch EA, Heijens CA, Horst NF, Center DM, Cruikshank WW: Cutting edge: IL-16/CD4 preferentially induces Th1 cell migration: requirement of CCR5. J Immunol. 2003, 171: 4965-4968.CrossRefPubMed
21.
go back to reference Sciaky D, Brazer W, Center DM, Cruikshank WW, Smith TJ: Cultured human fibroblasts express constitutive IL-16 mRNA: cytokine induction of active IL-16 protein synthesis through a caspase-3-dependent mechanism. J Immunol. 2000, 164: 3806-3814.CrossRefPubMed Sciaky D, Brazer W, Center DM, Cruikshank WW, Smith TJ: Cultured human fibroblasts express constitutive IL-16 mRNA: cytokine induction of active IL-16 protein synthesis through a caspase-3-dependent mechanism. J Immunol. 2000, 164: 3806-3814.CrossRefPubMed
22.
go back to reference Weis-Klemm M, Alexander D, Pap T, Schutzle H, Reyer D, Franz JK, Aicher WK: Synovial fibroblasts from rheumatoid arthritis patients differ in their regulation of IL-16 gene activity in comparison to osteoarthritis fibroblasts. Cell Physiol Biochem. 2004, 14: 293-300. 10.1159/000080339.CrossRefPubMed Weis-Klemm M, Alexander D, Pap T, Schutzle H, Reyer D, Franz JK, Aicher WK: Synovial fibroblasts from rheumatoid arthritis patients differ in their regulation of IL-16 gene activity in comparison to osteoarthritis fibroblasts. Cell Physiol Biochem. 2004, 14: 293-300. 10.1159/000080339.CrossRefPubMed
Metadata
Title
Direct interaction of immunoglobulins with synovial fibroblasts: a missing link in the pathogenesis of rheumatoid arthritis?
Author
Thomas Pap
Publication date
01-11-2004
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2004
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar1493

Other articles of this Issue 1/2004

Arthritis Research & Therapy 1/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.